CHICAGO -- As national health care undergoes reorganization, chain drug retailers are struggling to remain competitive. Survival will depend upon chain drug's ability to harness its inherent resources and fully integrate into the emerging health-care system, according to a J.P. Morgan analyst.
The realities of what chain drug retailers face in today's marketplace were driven home by Mark Husson, vice president at J.P. Morgan Securities, New York, during a presentation at the Alexandria, ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
Click here to read the FAQ page if you have any questions (opens in a new window)
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.
Already registered? Log In